Diagnamed Holdings Corp.
Diagnamed Holdings Corp.
CSE Index:
NoCurrency:
CAD DiagnaMed Holdings Corp. delivers innovative technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and AI-driven drug discovery and diagnostics.
Diagnamed Holdings Corp. (DMED)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
550 Burrard Street - #2900
Vancouver, BC V6C 0A3
CanadaPhone
1-855-439-2276Email
Info@diagnamed.comWebsite
https://www.diagnamed.comListing date
Tuesday, November 8, 2022Transfer Agent
Marrelli Trust Company LimitedSEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
550 Burrard Street - #2900
Vancouver, BC V6C 0A3
CanadaPhone
1-855-439-2276Email
Info@diagnamed.comWebsite
https://www.diagnamed.comListing date
Tuesday, November 8, 2022Transfer Agent
Marrelli Trust Company LimitedCapitalization
Issued & Outstanding:
81408640Reserved for Issuance:
6250000Company Officers
Fabio Chianelli , President, Chief Executive Officer
Jing Peng, Chief Financial Officer and Corporate Secretary
Bulletins
07/11/2022
2022-1109 - New Listing - Diagnamed Holdings Corp. (DMED)
Le 7 novembre/November 2022
The common shares of Diagnamed Holdings Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
